{"id":"W2141501933","doi":"10.1136/thoraxjnl-2012-202606","title":"Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β<sub>2</sub>agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial","year":2013,"lang":"en","type":"article","venue":"Thorax","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences","funders":"UCB Pharma; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Genentech; AstraZeneca; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Fluticasone propionate; Tolerability; Asthma; Corticosteroid; Adverse effect; Internal medicine; Gastroenterology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003500931,0.0001642973,0.0004491688,0.0000526745,0.00006554351,0.00002710283,0.0001052118,0.00006601951,0.000005384595],"category_scores_gemma":[0.0001435576,0.00008506893,0.00005918387,0.000164302,0.0002577839,0.00009018233,0.00004542291,0.0001604069,0.000001170621],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005920814,"about_ca_system_score_gemma":0.0001206839,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002835541,"about_ca_topic_score_gemma":0.0001407054,"domain_scores_codex":[0.9986416,0.0001698673,0.0004463853,0.0002560361,0.0002753329,0.0002108437],"domain_scores_gemma":[0.9990277,0.0002025976,0.0002439615,0.0003271568,0.000115465,0.00008315714],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7583717,0.003759273,0.188664,0.0003252153,0.0001134289,0.00001621437,0.002162806,0.00003037005,0.02510037,0.00002760604,0.00007028355,0.02135881],"study_design_scores_gemma":[0.247026,0.002835312,0.7469042,0.0002342346,0.0000715268,0.000006809461,0.0002565075,0.0004534844,0.002058582,0.000007759864,0.0000385371,0.0001069951],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942974,0.00002970185,0.0001654503,0.0004567559,0.00005331186,0.004914376,0.00003572407,0.00001061204,0.00003666928],"genre_scores_gemma":[0.9993736,0.000003209252,0.00004723528,0.0002589117,0.00002168948,0.0002320097,0.00001829252,0.00001957189,0.00002549681],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5582402,"threshold_uncertainty_score":0.346901,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01108943881476582,"score_gpt":0.2355578585111051,"score_spread":0.2244684196963393,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}